Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,283 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07726706Enrolling by invitation
Robotic walking device use during school hours
This pilot study tests whether students can use a robotic walking device during the school day. It looks at how well it works and how students and staff feel about using it.
Calgary, AlbertaAges Any age - NCT07720375RecruitingPhase 2
Study of galvokimig for non-cystic fibrosis bronchiectasis
This study tests a new medicine called galvokimig for adults with non-cystic fibrosis bronchiectasis, a condition where airways are damaged and cause chronic cough and sputum. The goal is to see if it reduces flare-ups and improves lung health.
Brandon, FloridaAges 18–80 - NCT07717905RecruitingPhase 1/Phase 2
Testing BBT001 for chronic hives
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
Wuhu, AnhuiAges 18–75 - NCT07718165RecruitingPhase 1
Study of ABSK211 for advanced solid tumors with KRAS changes
This trial tests a new drug called ABSK211 in people with advanced solid tumors that have a change in the KRAS gene. The goal is to see if the drug is safe and works against the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07715175RecruitingPhase 1
D-2570 in people with different kidney function
This study tests how a new drug, D-2570, is processed by the body in people with normal or reduced kidney function. It aims to understand if kidney function affects how the drug works, which could help guide dosing.
Hefei, AnhuiAges 18–70 - NCT07720284RecruitingPhase 3
Testing new drugs for high-risk bladder cancer after surgery
This trial tests a new combination of drugs (Dato-DXd plus rilvegostomig) against standard treatments for people with high-risk, muscle-invasive bladder cancer that has been surgically removed. The goal is to see if the new treatment reduces the chance of the cancer coming back.
Hot Springs, ArkansasAges 18 years+ - NCT07716410Recruiting
Study of Cryptosporidium in Children with Diarrhea
This study follows children aged 6 months to 5 years with diarrhea caused by Cryptosporidium. It aims to understand how the infection develops over time and how it affects children.
Kisumu, NyanzaAges 6 months–4.9 years - NCT07716098RecruitingPhase 3
Esketamine nasal spray for treatment-resistant depression
This study tests esketamine nasal spray versus a placebo in adults with depression that has not improved after trying at least two other antidepressants. It aims to see if the spray can help when standard pills have not worked.
Redlands, CaliforniaAges 18 years+ - NCT07719920RecruitingPhase 1
Study of HW221043 for advanced solid tumors
This trial is testing a new oral drug called HW221043 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and how well it works.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07721402RecruitingPhase 1
How prifetrastat is absorbed in healthy adults
This study tests how different forms of the study medicine prifetrastat enter the blood. It may help researchers understand the best way to give the medicine in future studies.
Brussels, Bruxelles-capitale, Région deAges 18 years+ - NCT07722429Recruiting
Personalized spinal stimulation for arm function after spinal injury
This study tests a personalized electrical stimulation treatment placed near the spine to see if it can improve arm and hand function after a spinal cord injury. If you have a stable injury above the mid-back and have not had new nerve problems in the last 6 months, you may be able to join.
Hualien CityAges 18–70 - NCT05902559Recruiting
Study of new lung-check biomarkers in older adults
This study looks at new blood or test “biomarkers” to understand how well targeted lung health checks work. You join if you’re already attending the NHS lung health check program and can consent.
LondonAges 55–74 - NCT07712640RecruitingPhase 1
Comparing two tablet forms of BGB-58067 and food effect
This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.
Adelaide, South AustraliaAges 18–65 - NCT07710768RecruitingPhase 1
A study on how UBT251 affects certain drugs in people with extra weight
This study tests if a new medicine called UBT251 changes how the body processes caffeine, midazolam (a sedative), and warfarin (a blood thinner). It is for generally healthy adults with a Body Mass Index (BMI) between 27 and 40.
Cypress, CaliforniaAges 18–65 - NCT07712575RecruitingPhase 1
V132 vaccine study for healthy older adults
This trial tests a new vaccine called V132 in healthy older people. It aims to see if the vaccine is safe and how the body responds to it.
Anaheim, CaliforniaAges 50–75 - NCT07710664RecruitingPhase 1
New drug for persistent anal HPV16 infection
This trial tests a new drug (NWRD09) for people who have had HPV type 16 infection in the anal area for over a year. It aims to see if the drug can help clear the virus without causing serious side effects.
BeijingAges 18–60 - NCT07713264Recruiting
Outdoor workers' safety study in California
This study listens to outdoor workers and community members in three California counties to understand safety needs. Participants will use a smartphone app or a provided phone to share what they see in their community.
Stanford, CaliforniaAges 18 years+ - NCT07705607RecruitingPhase 3
Comparing MK-8748 to standard treatment for diabetic eye swelling
This trial tests a new medicine (MK-8748) against an existing treatment (aflibercept) for people with diabetic macular edema, which causes vision loss due to swelling in the back of the eye. The goal is to see which works better to improve or protect vision.
Winter Haven, FloridaAges 18 years+ - NCT07705555RecruitingPhase 3
Comparing a new eye injection to standard treatment for diabetic eye swelling
This trial tests if a new medicine (MK-8748) works as well as or better than the usual treatment (aflibercept) for people with diabetic macular edema, a condition that causes vision loss from diabetes-related swelling in the back of the eye.
Glendale, CaliforniaAges 18 years+ - NCT07704892RecruitingPhase 3
Study of efimosfermin for adults with cirrhosis from MASH
This trial tests a new drug, efimosfermin, to see if it is safe and effective for people with cirrhosis caused by MASH (a type of fatty liver disease). It may help improve liver health compared to a placebo.
Little Rock, ArkansasAges 18–75 - NCT07704099RecruitingPhase 2
Study of KER-065 for Duchenne Muscular Dystrophy
This study tests a new medication called KER-065 to see if it helps people with Duchenne Muscular Dystrophy (DMD). It may help boys and men who are still walking, as well as those who use a wheelchair, as long as they are on a stable corticosteroid treatment.
Auckland, North IslandAges 9 years+ - NCT07700758RecruitingPhase 2
Belzutifan for teenagers with solid tumors
This study tests an oral drug called belzutifan in teenagers with certain solid tumors. Belzutifan may shrink tumors by blocking a protein that helps them grow.
Iowa City, IowaAges 12–17 - NCT07700979RecruitingPhase 3
Testing a new drug combo for stomach cancer
This trial tests a new immunotherapy drug called cadonilimab combined with chemotherapy for people with advanced stomach cancer that hasn't been treated yet. It compares this combination to chemotherapy with or without another immunotherapy drug, nivolumab.
Phoenix, ArizonaAges 18 years+ - NCT07700056RecruitingPhase 3
Study of remibrutinib for severe itching of unknown cause
This study tests an investigational medicine (remibrutinib) for people with severe itching that has no known cause. It may help reduce the itch when moisturizers haven't worked.
Miami, FloridaAges 18 years+
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,283 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.